首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC).
【24h】

Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC).

机译:非小细胞肺癌(NSCLC)中巨噬细胞,肥大细胞和嗜酸性粒细胞白细胞与血管生成和肿瘤分期的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

The association between inflammatory cells, including tumor associated macrophage (TAM), mast cell (MC) and eosinophil leucocyte (EL) densities and angiogenesis, as well as the relation of TAM, MC and EL densities and angiogenesis to tumor stage were investigated in specimens of 63 non-small cell lung carcinoma (NSCLC). Fifteen cases were in stage I, 12 were in stage II, 33 were in stage III and 3 were in stage IV. ELs and MCs were identified by hematoxilen-eosin and toluidine-blue histochemical stains, respectively. TAMs were shown by immunohistochemistry for CD68. Microvessels demonstrated by immunohistochemistry for CD31 were quantified by a stereological method and vascular surface density (VSD) and microvessel number (NVES) were calculated. There was not any statistically significant correlation between tumor's stage and VSD, TAM and EL counts. MC count and NVES were found to be higher in early stages. VSD and NVES were not associated with EL, MC and TAM counts. The lack of consistent correlation of angiogenesis to the stage of disease in this study supports the view that tumor angiogenesis is not a significant prognostic factor in NSCLCs. The absence of correlation between MCs, ELs and TAM counts and angiogenesis and absence of any relation between ELs and TAMs and tumor stage are discordant with the results of some of the previous studies in NSCLCs and in other tumors. The differing results may be due to wide variations in methodologies which were used for demonstration of inflammatory cells and vessels and variations in the degree of activation and complexity of functions of these cells.
机译:在标本中研究了炎症细胞,包括肿瘤相关巨噬细胞(TAM),肥大细胞(MC)和嗜酸性白细胞(EL)密度与血管生成之间的关系,以及TAM,MC和EL密度与血管生成与肿瘤阶段的关系。 63个非小细胞肺癌(NSCLC)中的比例。 I期15例,II期12例,III期33例,IV期3例。 ELs和MCs分别由血红素-曙红和甲苯胺蓝组织化学染色鉴定。通过针对CD68的免疫组织化学显示TAM。通过立体组织学方法对通过CD31免疫组织化学证实的微血管进行定量,并计算血管表面密度(VSD)和微血管数目(NVES)。肿瘤的分期与VSD,TAM和EL计数之间无统计学意义的相关性。早期发现MC计数和NVES较高。 VSD和NVES与EL,MC和TAM计数无关。在这项研究中,缺乏与血管生成与疾病阶段一致的相关性,支持了以下观点:肿瘤血管生成不是NSCLC中重要的预后因素。 MC,ELs和TAM计数与血管生成之间不存在相关性,以及ELs和TAM与肿瘤分期之间不存在任何关系与先前在NSCLC和其他肿瘤中进行的一些研究结果不一致。不同的结果可能是由于用于证明炎症细胞和血管的方法的广泛差异以及这些细胞的激活程度和功能复杂性的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号